Abstract IA004: Functional Precision Oncology in Rare Cancers: From Biobank to Drug Discovery
This approach identified Polo-like kinase 1 (PLK1) as a therapeutic vulnerability in fibrolamellar carcinoma, an ultra-rare liver cancer driven by the DNAJB1-PRKACA fusion, illustrating how functional and computational approaches can uncover actionable dependencies in rare cancers.